Skip to content
healthcare.dev

mesalamine

NDC 68382-711, mesalamine, tablet, delayed release, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-711
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091640
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-711 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
68382-711-1968382071119120 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-711-19)
68382-711-646838207116434 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-711-64)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/533bfaf5-0add-4b49-a4f2-ddea2b83f65d
  • NADAC price for package 68382071119

    GET /v1/drugs/nadac/68382071119

Use it

Look up 68382-711 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-711 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-711. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.